Close X
Monday, December 2, 2024
ADVT 
International

WHO says Equatorial Guinea confirms 1st outbreak of Marburg

Darpan News Desk The Canadian Press, 13 Feb, 2023 01:58 PM
  • WHO says Equatorial Guinea confirms 1st outbreak of Marburg

Photo courtesy of IStock. 

DAKAR, Senegal (AP) — The World Health Organization says that Equatorial Guinea has confirmed its first-ever outbreak of Marburg disease, saying the Ebola-related virus is responsible for at least nine deaths in the tiny Western African country.

In a statement on Monday, the U.N. health agency confirmed the epidemic after samples from Equatorial Guinea were sent to a lab in Senegal to pinpoint the cause of disease after an alert from a local health official last week.

The WHO said there were currently nine deaths and 16 suspected cases with symptoms including fever, fatigue, diarrhea and vomiting. The agency said it was sending medical experts to help officials in Equatorial Guinea stop the outbreak and was also sending protective equipment for hundreds of workers.

Like Ebola, the Marburg virus originates in bats and spreads between people via close contact with the bodily fluids of infected people, or surfaces, like contaminated bed sheets. Without treatment, Marburg can be fatal in up to 88% of people.

The rare virus was first identified in 1967 after it caused simultaneous outbreaks of disease in laboratories in Marburg, Germany and Belgrade, Serbia. Seven people died who were exposed to the virus while conducting research on monkeys.

There are no authorized vaccines or drugs to treat Marburg, but rehydration treatment to alleviate symptoms can improve the chances of survival.

In a 2004 outbreak in Angola, Marburg killed 90% of 252 people infected. Last year, there were two reported Marburg deaths in Ghana.

MORE International ARTICLES

AstraZeneca resuming US testing of COVID-19 vaccine

AstraZeneca resuming US testing of COVID-19 vaccine
The AstraZenca vaccine, developed with Oxford University, is one of several coronavirus vaccine candidates in final-stage testing around the world.

AstraZeneca resuming US testing of COVID-19 vaccine

FDA approves first COVID-19 drug: antiviral remdesivir

FDA approves first COVID-19 drug: antiviral remdesivir
The drug, which California-based Gilead Sciences Inc. is calling Veklury, cut the time to recovery by five days — from 15 days to 10 on average — in a large study led by the U.S. National Institutes of Health.

FDA approves first COVID-19 drug: antiviral remdesivir

Here we go again: Trump, Biden reprise debate duel

Here we go again: Trump, Biden reprise debate duel
Instead, they're bracing for another show of vintage Trump, one in which he'll seek to be heard even in spite of his muted microphone.

Here we go again: Trump, Biden reprise debate duel

Getting ready for the gong show: Trump v. Biden II

Getting ready for the gong show: Trump v. Biden II
It's the sequel to last month's debate horror show between Donald Trump and Joe Biden, an invective-laced 90 minutes that laid bare the depths to which political discourse can sink in an American election year.

Getting ready for the gong show: Trump v. Biden II

US overdose deaths appear to rise amid coronavirus pandemic

US overdose deaths appear to rise amid coronavirus pandemic
Davidson lost his job. He started staying home alone in his apartment near Georgetown, Kentucky — depressed and yearning for his recovery support group that had stopped gathering in person, said his cousin Melanie Wyatt.

US overdose deaths appear to rise amid coronavirus pandemic

Pfizer: Mid-November earliest it can seek virus vaccine OK

Pfizer: Mid-November earliest it can seek virus vaccine OK
Another leading U.S. contender, Moderna Inc., previously announced the earliest it could seek authorization of its own vaccine would be Nov. 25.

Pfizer: Mid-November earliest it can seek virus vaccine OK